KeyCorp Forecasts Alpha Teknova FY2027 Earnings

Alpha Teknova, Inc. (NASDAQ:TKNO) – Equities research analysts at KeyCorp issued their FY2027 earnings per share estimates for shares of Alpha Teknova in a report released on Wednesday, November 4th. KeyCorp analyst P. Knight anticipates that the company will earn ($0.20) per share for the year. The consensus estimate for Alpha Teknova’s current full-year earnings is ($0.26) per share.

Alpha Teknova (NASDAQ:TKNO) last announced its quarterly earnings results on Wednesday, November 4th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.01. Alpha Teknova had a negative return on equity of 24.95% and a negative net margin of 34.76%. The business had revenue of $12.70 million for the quarter, compared to analyst estimates of $11.71 million.

A number of other equities analysts have also recently issued reports on the company. Wall Street Zen upgraded Alpha Teknova from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. BTIG Research raised shares of Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 price target for the company in a research report on Tuesday, August 11th. Weiss Ratings restated a “sell (e+)” rating on shares of Alpha Teknova in a research note on Wednesday, November 4th. Zacks Research upgraded shares of Alpha Teknova to a “hold” rating in a report on Thursday, August 6th. Finally, TD Cowen upped their price objective on shares of Alpha Teknova from $7.00 to $11.00 and gave the stock a “buy” rating in a report on Tuesday, October 13th. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $8.75.

Alpha Teknova Trading Down 3.7%

NASDAQ TKNO opened at $8.30 on Friday. The company has a quick ratio of 3.48, a current ratio of 3.56 and a debt-to-equity ratio of 0.22. Alpha Teknova has a 52 week low of $1.91 and a 52 week high of $9.48. The business has a 50 day moving average price of $7.83 and a 200-day moving average price of $5.09. The company has a market cap of $522.07 million, a price-to-earnings ratio of -28.62 and a beta of 0.96.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Susquehanna International Group LLP purchased a new position in shares of Alpha Teknova during the second quarter valued at approximately $115,000. Bank of America Corp DE purchased a new stake in Alpha Teknova in the 2nd quarter valued at $1,453,000. Ieq Capital LLC purchased a new stake in Alpha Teknova in the 2nd quarter valued at $62,000. BlackRock Inc. purchased a new stake in Alpha Teknova in the 2nd quarter valued at $4,997,000. Finally, Deutsche Bank AG purchased a new stake in Alpha Teknova in the 2nd quarter valued at $62,000. Institutional investors own 13.81% of the company’s stock.

About Alpha Teknova

Alpha Teknova, Inc. develops and manufactures reagents used in life science research and the development and production of biopharmaceuticals and diagnostic products. Its offerings include cell culture media, buffers, molecular biology reagents, proteins and other laboratory materials. The company provides both catalog products and custom reagent development and manufacturing services. Its customers include biotechnology and pharmaceutical companies, diagnostic developers, academic institutions and research laboratories.